28.8 C
New York
Saturday, June 6, 2026

Tag: runway

Unlocking Your Future: How Plug Power’s Latest Earnings Empower Women Investors

Hey there, fabulous finance queens! 💁‍♀️ Let’s dive into the world of hydrogen energy with a company that’s been making waves lately: Plug Power....

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with Janus Henderson Investors, a global asset management firm, for the purchase and sale of 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period. 

Pre-NYFW Rendezvous for the Industry Elite: Daylight Studio Hosts Exclusive Networking Event

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Daylight Studio, a premier creative space renowned for hosting high-profile fashion campaigns, will welcome leading designers, stylists,...

Mobilicom Reports Financial and Operational Results for the Six Months Ended June 30, 2025

Momentum accelerates with $1.5 million in revenue for H1 2025 and an order backlog of $1.6 million as of June 30, bringing the combined total to $3.1 million — already approaching full-year 2024 revenue, as new sales continue to ramp in the second half of 2025

LivePerson Announces Deleveraging Transaction

Enters into agreement to exchange $341.1 million of its outstanding 2026 Convertible Senior Notes for $45.0 million in cash, $115.0 million of 2029 Senior...

Avalanche and Helika Launch New Gaming Accelerator – Applications Now Open

TORONTO, Aug. 11, 2025 /PRNewswire/ -- The Avalanche Foundation and Helika, a leading provider of technical and creative solutions for the video games industry,...

The Next Gold Boom May Not Be in Bullion–It’s in the Miners

Issued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 8, 2025 /PRNewswire/ -- USA News Group News Commentary – On the brink of...

The Next Gold Boom May Not Be in Bullion–It’s in the Miners

Issued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 8, 2025 /CNW/ -- USA News Group News Commentary – On the brink of...

The Next Gold Boom May Not Be in Bullion–It’s in the Miners

Issued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 8, 2025 /PRNewswire/ -- USA News Group News Commentary – On the brink of...

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights.

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates

JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.

Heven Unveils New Facility in Downtown Bingen

Ribbon-Cutting Marks New Chapter for Hydrogen-Powered Drone Innovation in the Columbia River Gorge BINGEN, Wash., Aug. 8, 2025 /PRNewswire/ -- Zepher Flight Labs (ZFL), now...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRunway